Wall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA) reports results for the ...

Moderna (MRNA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update revealing the long‑term results from a cancer therapy study.

Moderna faces a $5b patent infringement lawsuit over its COVID-19 vaccine, now moving to trial after a key court ruling. The company is also appointing Dr. David Berman as Chief Development Officer, ...

Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.

While Moderna has outpaced the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook about the stock’s ...

Moderna (MRNA) stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return. The company’s value has increased by approximately $1.2 billion over ...

MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for ...